Department of Obstetrics and Gynecology, Stanford University, Stanford, California, USA.
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, California, USA.
Paediatr Perinat Epidemiol. 2024 Jul;38(5):435-439. doi: 10.1111/ppe.13076. Epub 2024 Mar 21.
The 10th revision of the International Classification of Diseases, Clinical Modification (ICD-10) includes diagnosis codes for placenta accreta spectrum for the first time. These codes could enable valuable research and surveillance of placenta accreta spectrum, a life-threatening pregnancy complication that is increasing in incidence.
We sought to evaluate the validity of placenta accreta spectrum diagnosis codes that were introduced in ICD-10 and assess contributing factors to incorrect code assignments.
We calculated sensitivity, specificity, positive predictive value and negative predictive value of the ICD-10 placenta accreta spectrum code assignments after reviewing medical records from October 2015 to March 2020 at a quaternary obstetric centre. Histopathologic diagnosis was considered the gold standard.
Among 22,345 patients, 104 (0.46%) had an ICD-10 code for placenta accreta spectrum and 51 (0.23%) had a histopathologic diagnosis. ICD-10 codes had a sensitivity of 0.71 (95% CI 0.56, 0.83), specificity of 0.98 (95% CI 0.93, 1.00), positive predictive value of 0.61 (95% CI 0.48, 0.72) and negative predictive value of 1.00 (95% CI 0.96, 1.00). The sensitivities of the ICD-10 codes for placenta accreta spectrum subtypes- accreta, increta and percreta-were 0.55 (95% CI 0.31, 0.78), 0.33 (95% CI 0.12, 0.62) and 0.56 (95% CI 0.31, 0.78), respectively. Cases with incorrect code assignment were less morbid than cases with correct code assignment, with a lower incidence of hysterectomy at delivery (17% vs 100%), blood transfusion (26% vs 75%) and admission to the intensive care unit (0% vs 53%). Primary reasons for code misassignment included code assigned to cases of occult placenta accreta (35%) or to cases with clinical evidence of placental adherence without histopatholic diagnostic (35%) features.
These findings from a quaternary obstetric centre suggest that ICD-10 codes may be useful for research and surveillance of placenta accreta spectrum, but researchers should be aware of likely substantial false positive cases.
《国际疾病分类》第 10 次修订版(ICD-10)首次纳入了胎盘植入谱系疾病的诊断编码。这些编码可以为胎盘植入谱系疾病的有价值的研究和监测提供便利,因为这种疾病是一种危及生命的妊娠并发症,其发病率正在上升。
我们旨在评估 ICD-10 中引入的胎盘植入谱系疾病诊断编码的有效性,并评估导致编码错误的因素。
我们在一家四级产科中心回顾了 2015 年 10 月至 2020 年 3 月的病历,计算了 ICD-10 胎盘植入谱系疾病编码分配的敏感性、特异性、阳性预测值和阴性预测值。组织病理学诊断被认为是金标准。
在 22345 名患者中,有 104 名(0.46%)患者有 ICD-10 胎盘植入谱系疾病编码,51 名(0.23%)患者有组织病理学诊断。ICD-10 编码的敏感性为 0.71(95%CI 0.56,0.83),特异性为 0.98(95%CI 0.93,1.00),阳性预测值为 0.61(95%CI 0.48,0.72),阴性预测值为 1.00(95%CI 0.96,1.00)。ICD-10 胎盘植入谱系疾病亚型(粘连性、植入性和穿透性)的编码敏感性分别为 0.55(95%CI 0.31,0.78)、0.33(95%CI 0.12,0.62)和 0.56(95%CI 0.31,0.78)。编码错误分配的病例比正确分配的病例病情较轻,分娩时子宫切除的发生率较低(17%比 100%),输血的发生率较低(26%比 75%),入住重症监护病房的发生率较低(0%比 53%)。编码错误分配的主要原因包括将编码分配给隐匿性胎盘植入病例(35%)或具有胎盘粘连临床证据但无组织病理学诊断特征的病例(35%)。
这项来自四级产科中心的研究结果表明,ICD-10 编码可能对胎盘植入谱系疾病的研究和监测有用,但研究人员应该意识到可能存在大量的假阳性病例。